Clostridium difficile infection: new developments in epidemiology and pathogenesis
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Clostridium difficile is now considered to be one of the most important causes of health care-associated infections. C. difficile infections are also emerging in the community and in animals used for food, and are no longer viewed simply as unpleasant complications that follow antibiotic therapy. Since 2001, the prevalence and severity of C. difficile infection has increased significantly, which has led to increased research interest and the discovery of new virulence factors, and has expanded and focused the development of new treatment and prevention regimens. This Review summarizes the recent epidemiological changes in C. difficile infection, our current knowledge of C. difficile virulence factors and the clinical outcomes of C. difficile infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, studies have demonstrated that patients suffering from recurrent CDI are deficient in phyla of bacteria normally dominant in the colon6,45 (Figure 1).”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [45]
Citations
Cites
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361 · cited 1×
“It is becoming evident from 16S ribosomal RNA sequencing that disruption of the gut microbiota following antibiotic treatment is much greater than was previously realize”
BackgroundAn Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Nosocomial Acquisition of Clostridium difficile Infection
McFarland, L. V., Mulligan, M. E., Kwok, R. Y. Y., & Stamm, W. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901263200402 · Cited by 1,326
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
Pepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
Glucosylation of Rho proteins by Clostridium difficile toxin B
Just, I., Selzer, J., Wilm, M., Eichel-Streiber, C. V., Mann, M., & Aktories, K. (1995) · Nature · doi:10.1038/375500a0 · Cited by 1,032
Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Research works printed but not linked: 5
- Summary points on quarterly (October to December. 2008) and financial year (2007/08) acute Trust Clostridium difficile data. Key points: analyses of quarterly mandatory Clostridium difficile surveillance data. Health Protection Agency [online] , (2008).
- Thompson, A. et al. in Ninth Biennial Congress of the Anaerobe Society of Americas. PII-14 (Long Beach, California, 2008).
- Angulo, F. et al. in Second International Clostridium difficile Symposium. P5 (Maribor, Slovenia, 2007).
- Louie, T. et al. in The 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. K-425a (Chicago, Illinois, 2007).
- Merrigan, M. M., Gerding, D. N. & Vedantam, G. in Eighth Biennial Conference of the Anaerobe Society of America. PI-12 (Boise, Idaho, 2006).
Cited by
Items 701–800 of 999
Action of nitroheterocyclic drugs against Clostridium difficile
Kumar, M., Adhikari, S., & Hurdle, J. G. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.05.021 · Cited by 22
“difficile infection (CDI), with >14 000 deaths [1].”
BackgroundAn update on antibody-based immunotherapies for Clostridium difficile infection
Tanha, J., & Hussack, G. (2016) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s84017 · Cited by 22
Joshi, L. T., Mali, B. L., Geddes, C. D., & Baillie, L. W. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104334 · Cited by 22
“6 kb pathogenicity locus (PaLoc) which is present in all toxin producing strains [4–6].”
BackgroundShah, Z., Mahbuba, R., & Turcotte, B. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12223 · Cited by 22
“Another important pathogen is methicillin-resistant Staphylococcus aureus (MRSA), which has been proposed to be considered as a national priority for disease control in the United States (Klein et al., 2007).”
BackgroundDetection of DNA Amplicons of Polymerase Chain Reaction Using Litmus Test
Chang, D., Tram, K., Li, B., Feng, Q., Shen, Z., Lee, C., Salena, B. J., & Li, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-03009-z · Cited by 22
Complete Genome Sequence and Genomic Characterization of Lactobacillus acidophilus LA1 (11869BP)
Chung, W., Kang, J., Lim, M. Y., Lim, T.-J., Lim, S., Roh, S. W., & Nam, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00083 · Cited by 23
“Host genetics, diet, and environmental insults can affect the gut microbial composition (Human Microbiome Project Consortium, 2012), and disruption of the gut microbiota can lead to invasion and overgrowth of certain pathogenic bacteria, such as virulent Escherichia coli, Salmonella enterica serovar Typhimurium, and C…”
BackgroundClostridium difficile infection: a review
Kouhsari, E., Abbasian, S., Sedighi, M., Yaseri, H. F., Nazari, S., Bialvaei, A. Z., Dahim, P., Mirzaei, E. Z., & Rahbar, M. (2018) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000135 · Cited by 22
Kunishima, H., Ito, K., Laurent, T., & Abe, M. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.07.020 · Cited by 24
Kimura, T., Snijder, R. J., & Sugitani, T. (2019) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2019.03.011 · Cited by 23
Vigsnæs, L. K., Ghyselinck, J., den Abbeele, P. V., McConnell, B., Moens, F., Marzorati, M., & Bajic, D. (2021) · Pathogens · doi:10.3390/pathogens10080927 · Cited by 24
“therapy is considered as a key factor for host susceptibility to CDI [3,4].”
BackgroundRodrigues, R. S., Oliveira, R. A. C., Li, Y., Zaja‐Milatovic, S., Costa, L. B., Neto, M. B. B., Kolling, G. L., Lima, A. Â. M., Guerrant, R. L., & Warren, C. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit041 · Cited by 22
“rhea, pseudomembranous colitis, toxic megacolon, and even death [2].”
BackgroundSu, Y., Rohani, A., Warren, C. A., & Swami, N. S. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00050 · Cited by 23
Pizarro‐Guajardo, M., Calderón-Romero, P., Romero-Rodriguez, A., & Paredes‐Sabja, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01345 · Cited by 21
“Clostridioides difficile is the leading cause of nosocomial antibiotic-associated diarrhea (Rupnik et al., 2009; Martin et al., 2016).”
BackgroundTrends in the epidemiology of Clostridioides difficile infection in Germany
Vehreschild, M. J. G. T., Schreiber, S., von Müller, L., Epple, H., Weinke, T., Manthey, C. F., Oh, J. S., Wahler, S., & Stallmach, A. (2023) · Infection · doi:10.1007/s15010-023-02044-5 · Cited by 25
Islam, J., Cheek, E., Navani, V., Rajkumar, C., Cohen, J., & Llewelyn, M. (2013) · Journal of Hospital Infection · doi:10.1016/j.jhin.2013.06.009 · Cited by 21
“the gut microflora allow vegetative forms to adhere to the colonic mucosa and cause diarrhoea through toxin production.(2) Antibiotic treatment of acute C.”
BackgroundSynergistic inhibition of Clostridium difficile with nisin-lysozyme combination treatment
Chai, C., Lee, K., & Oh, S. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.04.003 · Cited by 21
New Perspectives in Clostridium difficile Disease Pathogenesis
Monaghan, T. M. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.11.007 · Cited by 30
Impact of deoxycholate on Clostridioides difficile growth, toxin production, and sporulation
Usui, Y., Ayibieke, A., Kamiichi, Y., Okugawa, S., Moriya, K., Tohda, S., & Saito, R. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03717 · Cited by 23
Yang, Z., Huang, Q., Qin, J., Zhang, X., Jian, Y., Lv, H., Liu, Q., & Li, M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.578098 · Cited by 23
“CDI is one of the principal threats to hospitalized and immunocompromised patients, with clinical manifestations ranging from asymptomatic carriers or mild diarrhea to fulminant infectious colitis occasionally complicated by toxic megacolon, sepsis, and death (Rupnik et al., 2009; Brkic et al., 2016).”
BackgroundMiezeiewski, M., Schnaufer, T., Muravsky, M., Wang, S., Caro-Aguilar, I., Secore, S., Thiriot, D. S., Hsu, C. C., Rogers, I. T., DeSantis, T. Z., et al. (2014) · The ISME Journal · doi:10.1038/ismej.2014.127 · Cited by 21
“C. difficile affects about 500 000 Americans each year, accounting for 15 000–20 000 deaths (Rupnik et al., 2009) with similar incidence reported in both Canada and Europe (Poutanen & Simor, 2004).”
BackgroundResultBacterial spore-formers: friends and foes
Cutting, S. M., & Ricca, E. (2014) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12572 · Cited by 21
Corver, J., Cordo’, V., van Leeuwen, H. C., Klychnikov, O. I., & Hensbergen, P. J. (2017) · Molecular Microbiology · doi:10.1111/mmi.13736 · Cited by 20
Alverdy, J. C., Gilbert, J. A., DeFazio, J. R., Sadowsky, M. J., Chang, E. B., Morowitz, M. J., & Teitelbaum, D. H. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113517904 · Cited by 24
Clostridium difficile infection in Thailand
Putsathit, P., Kiratisin, P., Ngamwongsatit, P., & Riley, T. V. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.09.005 · Cited by 20
Equol inhibits growth and spore formation of Clostridioides difficile
Tanaka, Y., Kimura, S., Ishii, Y., & Tateda, K. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14353 · Cited by 19
“2016; Oren and Garrity 2018) is a Gram-positive, spore-forming, toxin-producing, anaerobic bacterium, which has established itself as a leading cause of nosocomial antibiotic-associated diarrhoea in developed countries (Rupnik et al. 2009; Chakra et al., 2014).”
BackgroundLearning from Nature: Bacterial Spores as a Target for Current Technologies in Medicine (Review)
Andryukov, B. G., Karpenko, A. A., & Lyapun, I. N. (2020) · Современные технологии в медицине · doi:10.17691/stm2020.12.3.13 · Cited by 25
“The ability to adhere is known to be one of the key factors of virulence in this bacteria species [8, 9, 20].”
BackgroundMethodQi, H., Sun, Q., Ma, Y., Wu, P., & Wang, J. (2020) · Toxins · doi:10.3390/toxins12110722 · Cited by 20
Enteropathogenic Infections: Organoids Go Bacterial
Hentschel, V., Arnold, F., Seufferlein, T. T. W., Azoitei, N., Kleger, A., & Müller, M. (2021) · Stem Cells International · doi:10.1155/2021/8847804 · Cited by 22
Innate Lymphoid Cells and Their Role in the Immune Response to Infections
Fol, M., Karpik, W., Zabłotni, A., Kulesza, J., Kulesza, E., Godkowicz, M., & Druszczyńska, M. (2024) · Cells · doi:10.3390/cells13040335 · Cited by 26
“Clostridium difficile ( C. difficile ) is a Gram-positive spore-forming, toxin-producing anaerobe [135].”
BackgroundAktuelle Daten und Trends zur Antibiotikaresistenzentwicklung von Clostridium difficile
von Müller, L., Halfmann, A., & Herrmann, M. (2012) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-012-1556-6 · Cited by 22
Clostridium-DTDB: A comprehensive database for potential drug targets of Clostridium difficile
Jadhav, A., Ezhilarasan, V., Sharma, O. P., & Pan, A. (2013) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2013.01.009 · Cited by 20
“The clinical outcomes of CDI can vary from asymptomatic colonization to mild diarrhea and more severe disease syndromes, such as pseudomembranous colitis, toxic megacolon, bowel perforation, sepsis, shock, and death [1].”
BackgroundClostridium difficile TcdC protein binds four-stranded G-quadruplex structures
van Leeuwen, H. C., Bakker, D., Steindel, P. S., Kuijper, E. J., & Corver, J. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1448 · Cited by 29
“These toxins cause intestinal damage and ultimately clinical disease (5).”
BackgroundVehreschild, M. J. G. T., Meißner, A., Cornely, O. A., Maschmeyer, G., Neumann, S., von Lilienfeld‐Toal, M., Karthaus, M., Wattad, M., Staib, P., Hellmich, M., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.049627 · Cited by 20
“difficile-associated diarrhea, in this study we documented only a moderate incidence of 5% during first episodes of neutropenia.(25,26) The same was true for the incidence of C.”
BackgroundBradshaw, W. J., Kirby, J. M., Thiyagarajan, N., Chambers, C. J., Davies, A. H., Roberts, A. K., Shone, C. C., & Acharya, K. R. (2014) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s1399004714009997 · Cited by 20
“C. difficile infection (CDI) can lead to severe diarrhoea, pseudomembranous colitis, toxic megacolon and ultimately death (Kachrimanidou & Malisiovas, 2011; Rupnik et al., 2009).”
Clostridium difficile in ready-to-eat foods in Isfahan and Shahrekord, Iran
Rahimi, E., Afzali, Z. S., & Baghbadorani, Z. T. (2015) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(15)30156-8 · Cited by 20
Archbald‐Pannone, L. R., Boone, J. H., Carman, R. J., Lyerly, D. M., & Guerrant, R. L. (2014) · Journal of Hospital Infection · doi:10.1016/j.jhin.2014.06.016 · Cited by 20
Nosocomial Infections and their Surveillance in Veterinary Hospitals
Milton, A. A. P. (2015) · Advances in Animal and Veterinary Sciences · doi:10.14737/journal.aavs/2015/3.2s.1.24 · Cited by 32
Mortality in Clostridium difficile infection
Bloomfield, M. G., Carmichael, A., & Gkrania‐Klotsas, E. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835ed64d · Cited by 20
Džunková, M., Moyá, A., Vázquez-Castellanos, J. F., Artacho, A., Chen, X., Kelly, C. P., & D’Auria, G. (2016) · mSphere · doi:10.1128/msphere.00101-16 · Cited by 21
“CDI is commonly treated with the antibiotic vancomycin or metronidazole (1, 2).”
Kumar, S., Pollok, R., Muscat, I., & Planche, T. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13504 · Cited by 20
Sachsenheimer, F. E., Yang, I., Zimmermann, O., Wrede, C., von Müller, L., Gunka, K., Groß, U., & Suerbaum, S. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2018.02.002 · Cited by 23
Fühner, V., Heine, P. A., Helmsing, S., Goy, S., Heidepriem, J., Loeffler, F. F., Dübel, S., Gerhard, R., & Hust, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02908 · Cited by 20
Hasni, I., Chelkha, N., Baptiste, E., Mameri, M. R., Lachuer, J., Plasson, F., Colson, P., & Scola, B. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-54580-6 · Cited by 20
Erickson, S. L., Alston, L. A., Nieves, K., Chang, T. K. H., Mani, S., Flannigan, K. L., & Hirota, S. A. (2019) · The FASEB Journal · doi:10.1096/fj.201902083rr · Cited by 22
“This population was composed of three distinct innate cell populations: (1) monocytes (CD11b+Ly6Chi; green box), (2) neutrophils (CD11b+Ly6CintLy6G+; blue box), and (3) eosinophils (CD11b+Ly6CloSiglec−F+; red box).”
BackgroundThe Antimicrobial Stewardship Approach to Combating Clostridium Difficile
Wenzler, E., Mulugeta, S., & Danziger, L. H. (2015) · Antibiotics · doi:10.3390/antibiotics4020198 · Cited by 20
“It is known that antibiotic exposure nearly always precedes CDAD and that commonly prescribed broad-spectrum antibiotics have been particularly implicated [3,4].”
BackgroundLei, X.-H., & Bochner, B. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056545 · Cited by 27
“Emergent in North America, Europe, and Asia since 2003 [11,18,19,20,21,22], hypervirulent strains, represented and dominated by ribotype 027 or BI/NAP1/027, produce high levels of toxin A and toxin B, which is presumably due to their harboring a tcdC repressor gene mutated at several distinct sites (an 18-bp, a 36-bp,…”
BackgroundInfluentialWang, L., Villafuerte-Gálvez, J., Lee, C., Wu, S., Kelly, C. P., Chen, X., & Cao, Y. (2024) · iMeta · doi:10.1002/imt2.200 · Cited by 21
“In the United States, it results in significant healthcare expenditures [2, 3].”
BackgroundProteomic Analysis and Label-Free Quantification of the Large Clostridium difficile Toxins
Moura, H., Terilli, R. R., Woolfitt, A. R., Williamson, Y. M., Wagner, G., Blake, T. A., Solano, M. I., & Barr, J. R. (2013) · International Journal of Proteomics · doi:10.1155/2013/293782 · Cited by 23
“Accurate quantification of toxins can be accomplished using proteomic strategies which may reveal key information applicable to TcdA and TcdB method development, detection, understanding toxic mechanisms, and production of new therapeutics including polyclonal and monoclonal antibodies [2].”
BackgroundMethodInfluentialMarinescu, A. R., Laza, R., Musta, V., Cut, T. G., Dumache, R., Tudor, A., Poroșnicu, T. M., Lăzureanu, V. E., & Licker, M. (2021) · Medicina · doi:10.3390/medicina57101099 · Cited by 22
“Clostridium difficile infection (CDI), a serious medical condition of the large intestine, is the leading cause of healthcare-associated diarrhoea in Europe, with a recurrence rate of 15–20% and a mortality rate of 5% [10,11].”
BackgroundClostridioides difficile as a Potential Pathogen of Importance to One Health: A Review
Mitchell, M., Nguyen, S. V., Macori, G., Bolton, D., McMullan, G., Drudy, D., & Fanning, S. (2022) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2022.0037 · Cited by 23
“CDI can present in several ways ranging from: asymptomatic carriage, mild diarrhea, abdominal pain, fever, loss of appetite, leukocytosis to severe cases of in-flammatory lesions, pseudomembranous colitis (PMC), megacolon, and sepsis leading to shock and death (CDC, 2020a; Rupnik et al, 2009).”
InfluentialSaenz, C., Fang, Q., Gnanasekaran, T., Trammell, S. A. J., Buijink, J. A., Pisano, P., Wierer, M., Moens, F., Lengger, B., Brejnrod, A., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03933-22 · Cited by 19
Review Article: Gastroenterology and Clostridium difficile Infection: Past, Present, and Future
Kelly, C. R., & Allegretti, J. R. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad644 · Cited by 24
Saito, T., Kimura, S., Tateda, K., Mori, N., Hosono, N., Hayakawa, K., Akasaka, Y., Ishii, T., Sumiyama, Y., Kusachi, S., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr027 · Cited by 19
The Impact of Horizontal Gene Transfer on the Biology of Clostridium difficile
Roberts, A. P., Allan, E., & Mullany, P. P. (2014) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2014.08.002 · Cited by 20
Rapid and high-throughput construction of microbial cell-factories with regulatory noncoding RNAs
Chaudhary, A., Na, D., & Lee, E. Y. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.05.009 · Cited by 20
Application of Activity-Based Protein Profiling to the Study of Microbial Pathogenesis
Heal, W. P., & Tate, E. W. (2011) · Topics in current chemistry · doi:10.1007/128_2011_299 · Cited by 19
“difficile are the large glucosylating toxins TcdA and TcdB, and are thus of considerable interest as targets, especially TcdB, which is crucial for virulence and is found in all clinical isolates [13, 14].”
BackgroundAutoproteolytic Activation of Bacterial Toxins
Shen, A. (2010) · Toxins · doi:10.3390/toxins2050963 · Cited by 21
“that hyper-produces TcdA and TcdB causes more frequent and severe cases of CDIs [40,42].”
BackgroundHernández-Rocha, C., Barra, J., Álvarez-Lobos, M., Paredes‐Sabja, D., & Guzmán-Durán, A. M. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.12.010 · Cited by 19
“Clostridiumdifficile is amajornosocomial humanpathogen typically associated with antibiotic consumption, and the spectrum of the diseases can vary from mild diarrhea to fulminant colitis and death (Rupnik et al., 2009; Sarker and Paredes-Sabja, 2012).”
BackgroundAntimicrobial Susceptibility Patterns of Clostridium difficile Isolates from Family Dairy Farms
Bandelj, P., Golob, M., Ocepek, M., Zdovc, I., & Vengušt, M. (2016) · Zoonoses and Public Health · doi:10.1111/zph.12299 · Cited by 19
“It can cause CD infection (CDI) in humans and some animals, with clinical signs ranging from mild diarrhoea to severe pseudomembranous colitis and death (Rupnik et al., 2009).”
BackgroundAzimirad, M., Krůtová, M., Nyč, O., Hasani, Z., Afrisham, L., Alebouyeh, M., & Zali, M. R. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.05.004 · Cited by 18
Cheng, J.-W., Yang, Q.-W., Xiao, M., Yu, S.-Y., Zhou, M., Kudinha, T., Kong, F., Liao, J.-W., & Xu, Y. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2017.06.007 · Cited by 18
Assembly of the exosporium layer in Clostridioides difficile spores
Paredes‐Sabja, D., Cid-Rojas, F., & Pizarro‐Guajardo, M. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.01.008 · Cited by 18
García‐García, T., Douché, T., Gianetto, Q. G., Poncet, S., Omrani, N. E., Smits, W. K., Cuenot, E., Matondo, M., & Martin‐Verstraete, I. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100428 · Cited by 20
“difficile is a Gram-positive, spore-forming, anaerobic bacterium and is the leading cause of antibiotic-associated nosocomial diarrhea (23).”
BackgroundBassotti, G., Fruganti, A., Stracci, F., Marconi, P., & Fettucciari, K. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i4.582 · Cited by 19
Non-Toxin-Based Clostridioides difficile Vaccination Approaches
Razim, A., Górska, S., & Gamian, A. (2023) · Pathogens · doi:10.3390/pathogens12020235 · Cited by 22
“Symptoms of CDI range from mild diarrhea and abdominal pain to pseudomembranous colitis and, in the most severe case, may lead to distention of the colon, perforation of the intestine, and even death [5].”
Clostridioides difficile infections; new treatments and future perspectives
Normington, C., Chilton, C. H., & Buckley, A. M. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000989 · Cited by 27
Useh, N. M., & Num, S. M. (2014) · Jordan Journal of Biological Sciences · doi:10.12816/0008220 · Cited by 25
“difficile, the causative agent of antimicrobial- associated diarrhoea and pseudomembranous colitis, is currently one of the most important nosocomial pathogens because of its zoonotic nature (Rupnik et al., 2009).”
BackgroundClostridium difficile infections: do we know the real dimensions of the problem?
Tattevin, P., Buffet‐Bataillon, S., Donnio, P.-Y., Revest, M., & Michelet, C. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.04.009 · Cited by 18
“erroneously considered without risk, such as community-acquired CDI in patients with no recent antibiotic use(6-8), or CDI during pregnancy(9); iv) the devel opment and the diversification of diagnostic tests, in-house or commercial, much faster than the pace of recommendations available to guide their use in routine…”
BackgroundFecal microbiota transplantation for Clostridium difficile infection: back to the future
Borgia, G., Maraolo, A. E., Foggia, M., Buonomo, A. R., & Gentile, I. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1045872 · Cited by 22
“difficile infection (CDI) is responsible for a spectrum of intestinal diseases ranging from mild diarrhea to severe, potentially fatal pseudomembranous colitis [5].”
BackgroundBed Occupancy Rates and Hospital-Acquired Clostridium difficile Infection: A Cohort Study
Ahyow, L., Lambert, P. C., Jenkins, D. R., Neal, K. R., & Tobin, M. D. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/673156 · Cited by 18
“In 2005, molecular analysis identified the hy- tors, such as hand hygiene and cleaning practices.(2) pervirulent strain as North American pulsed-field type 1 Organizational factors—such as staffing levels, skill mix, (NAP1), also known as ribotype 027.”
BackgroundVargo, C. A., Bauer, K. A. A., Mangino, J. E., Johnston, J., & Goff, D. A. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1451 · Cited by 18
Alicino, C., Giacobbe, D. R., Durando, P., Bellina, D., Bella, A., Paganino, C., Bono, V. D., Viscoli, C., Icardi, G., & Orsi, A. (2016) · Epidemiology and Infection · doi:10.1017/s0950268816000935 · Cited by 20
Muñoz, M., Ríos-Chaparro, D. I., Patarroyo, M. A., & Ramírez, J. D. (2017) · BMC Microbiology · doi:10.1186/s12866-017-0969-7 · Cited by 22
“In addition to these characteristics, homologous recombination events have been identified in CD (acquired intergene spacer mutations and RNA operons used for ribotyping) [31].”
Probiotics and Clostridium Difficile: A Review of Dysbiosis and the Rehabilitation of Gut Microbiota
Kalakuntla, A. S., Nalakonda, G., Nalakonda, K., Pidikiti, C. V., & Aasim, S. A. (2019) · Cureus · doi:10.7759/cureus.5063 · Cited by 22
Pal, R., & Seleem, M. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-63029-0 · Cited by 19
Brabb, T., Newsome, D., Burich, A., & Hanes, M. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-380920-9.00023-7 · Cited by 21
“In humans, administration of metronidazole or vancomycin is standard (Greenwood, 2007; Rupnik et al., 2009; Songer, 1996).”
Shuai, H., Bian, Q., Luo, Y., Zhou, X., Song, X., Ye, J., Huang, Q., Peng, Z., Wu, J., Jiang, J., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05030-6 · Cited by 18
“Background Clostridium difficile is a Gram-positive, anaerobic, spore forming bacterium that leads to healthcare-associated diarrhea and can be as life-threatening as pseudomembranous colitis, toxic megacolon, intestinal perforation, and septic shock [1].”
BackgroundGarcía‐García, T., Poncet, S., Cuenot, E., Douché, T., Gianetto, Q. G., Johann, P., Courtin, P., Chapot‐Chartier, M., Matondo, M., Dupuy, B., et al. (2021) · mBio · doi:10.1128/mbio.00519-21 · Cited by 21
“C. difficile is a Gram-positive, spore-forming, anaerobic bacterium and is the leading cause of antibiotic-associated nosocomial diarrhea (Rupnik et al., 2009).”
BackgroundForster, E. R., Yang, X., Tai, A., Hang, H. C., & Shen, A. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00463 · Cited by 20
RNA-based control mechanisms of Clostridium difficile
Soutourina, O. A. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.01.004 · Cited by 20
Structural insight into Wnt signaling inhibition by Clostridium difficile toxin B
Chen, P., Tao, L., Liu, Z., Dong, M., & Jin, R. (2018) · FEBS Journal · doi:10.1111/febs.14681 · Cited by 18
Zhou, J., Zhu, J., Zhang, P., Tao, C., Hong, X., & Zhang, Z. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01290-24 · Cited by 21
Zhang, K., Song, Z., Wang, Y., Zhu, X., Shen, H., Chen, Y., & Sun, X. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.09.009 · Cited by 18
Norsigian, C. J., Danhof, H. A., Ardis, C. K., Midani, F. S., Broddrick, J. T., Savidge, T., Britton, R. A., Palsson, B. Ø., Spinler, J. K., & Monk, J. M. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119396119 · Cited by 22
Fitzpatrick, F., Safdar, N., van Prehn, J., & Tschudin‐Sutter, S. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00274-2 · Cited by 19
Plaza-Garrido, Á., Barra, J., Macias, J. H., Carman, R. J., Fawley, W. N., Wilcox, M. H., Hernández-Rocha, C., Guzmán-Durán, A. M., Álvarez-Lobos, M., & Paredes‐Sabja, D. (2015) · Epidemiology and Infection · doi:10.1017/s0950268815002459 · Cited by 17
“Clostridium difficile is the leading cause of healthcare-associated diarrhoea in adults and the aetiological agent of antibiotic-associated colitis [1].”
BackgroundClostridium difficile Infection Among Veterans Health Administration Patients
Young‐Xu, Y., Kuntz, J. L., Gerding, D. N., Neily, J. B., Mills, P. D., Dubberke, E. R., Olsen, M. A. A., Kelly, C. P., & Mahé, C. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.138 · Cited by 17
Clostridium difficile ribotype 027 is not evenly distributed in Hesse, Germany
Arvand, M., & Bettge-Weller, G. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.04.006 · Cited by 17
Beran, V., Kuijper, E. J., Harmanus, C., Sanders, I. M. J. G., van Dorp, S. M., Knetsch, C. W., Janečková, J., Seidelova, A., Bareková, L., Tvrdík, J., et al. (2017) · Folia Microbiologica · doi:10.1007/s12223-017-0515-x · Cited by 17
Cheng, J.-W., Liu, C., Kudinha, T., Xiao, M., Yu, S.-Y., Yang, C.-X., Wei, M., Liang, G.-W., Shao, D.-H., Kong, F., et al. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.04.011 · Cited by 17
Contamination of hospital food with Clostridium difficile in Central Italy
Primavilla, S., Farneti, S., Petruzzelli, A., Drigo, I., & Scuota, S. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2018.10.008 · Cited by 17
Moukhaiber, R., Araj, G. F., Kissoyan, K. A. B., Cheaito, K. A., & Matar, G. M. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.6585 · Cited by 17
“Indeed, deletions are found most commonly in tcdA and to date no form of significant deletions in tcdB is found [4,13].”
BackgroundBandelj, P., Logar, K., Usenik, A. M., Vengušt, M., & Ocepek, M. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12102 · Cited by 19
“Domestic and farm animals, such as newborn piglets, calves, horses, dogs, and some birds, can also be clinically affected by the CD infection (CDI; Borriello et al., 1983; O’Neill et al., 1993; Songer et al., 2000; Weese et al., 2001a,b; Kiss & Bilkei, 2005; Rodriguez-Palacios et al., 2006; Keel et al., 2007; Zidaric…”
BackgroundA Low Complexity Rapid Molecular Method for Detection of Clostridium difficile in Stool
McElgunn, C. J., Pereira, C., Parham, N. J., Smythe, J. E., Wigglesworth, M. J., Smielewska, A., Parmar, S., Gandelman, O. A., Brown, N. M., Tisi, L. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083808 · Cited by 17
Press, A., Ku, B. S., McCullagh, L., Rosen, L. M., Richardson, S. I., & McGinn, T. G. (2016) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2016.97 · Cited by 17
Fehlbaum, S., Chassard, C., Poeker, S. A., Derrien, M., Fourmestraux, C., & Lacroix, C. (2016) · Gut Pathogens · doi:10.1186/s13099-016-0144-y · Cited by 23
“CD is a gram-positive anaerobic bacterium harboring several virulence factors such as the ability to form spores and produce toxins [2].”
BackgroundEffect of DS-2969b, a novel GyrB inhibitor, on rat and monkey intestinal microbiota
Kumar, M., Mathur, T., Joshi, V., Upadhyay, D. J., Inoue, S., & Masuda, N. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2018.04.017 · Cited by 17
The Infectious Disease Ontology in the Age of COVID-19Preprint
Babcock, S., Beverley, J., Cowell, L. G., & Smith, B. (2020) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/az6u5 · Cited by 26
Maikova, A., Boudry, P., Shiriaeva, A., Vasileva, A., Boutserin, A., Medvedeva, S., Semenova, E., Severinov, K., & Soutourina, O. A. (2021) · mBio · doi:10.1128/mbio.02136-21 · Cited by 15
Azimirad, M., Noori, M., Azimirad, F., Gholami, F., Naseri, K., Yadegar, A., Aghdaei, H. A., & Zali, M. R. (2022) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-022-00533-3 · Cited by 16
Metadata
- Authors
- Rupnik, M., Wilcox, M. H., & Gerding, D. N.
- Affiliations
- University of Maribor (SI)
- Leeds General Infirmary (GB)
- Loyola University Chicago (US)
- Venue
- Nature Reviews Microbiology
- Published
- 2009-07
- Volume
- 7
- Issue
- 7
- Pages
- 526-536
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1968953113
- Cited by
- 1,380
- References
- 124
- Citations by year
- 2026: 18 · 2025: 36 · 2024: 49 · 2023: 59 · 2022: 74 · 2021: 72 · 2020: 88 · 2019: 78 · 2018: 109 · 2017: 104 · 2016: 107 · 2015: 107 · 2014: 133 · 2013: 141 · 2012: 93
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- Clostridium difficile infection, nosocomial infections, virulence factors, epidemiology, pathogenesis, community-acquired infections, food-producing animals, antibiotic-associated diarrhea, clinical outcomes, infection prevention and treatment
- MeSH terms
- Animals, Anti-Bacterial Agents, Enterocolitis, Pseudomembranous, Humans, Models, Theoretical, Clostridioides difficile, Virulence Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.